Discover 468 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 468
Active & Responsive
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
for
PTSD
Location: Grand Rapids MI, Battle Creek MI, Flint MI,
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05457985
Recruiting
Active & Responsive
Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
Location: Grand Rapids MI, Corunna MI, Midland MI, Flint MI,
Sponsor: Michigan State University
Sex: Female
Age: 18+
Code: NCT07213284
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Grand Rapids MI, Wyoming MI, Norton Shores MI,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Grand Rapids MI, Wyoming MI, Norton Shores MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase 2, Recruiting
Active & Responsive
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Location: Grand Rapids MI, Wyoming MI, Norton Shores MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07018869
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
for
Plasma Cell Myeloma
Location: Grand Rapids MI, Wyoming MI, Norton Shores MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT05561387
Phase 3, Recruiting
Active & Responsive
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
for
Ampulla of Vater Carcinoma, Appendix Carcinoma,
Location: Grand Rapids MI, Wyoming MI, Muskegon MI, Kalamazoo MI,
Location: Grand Rapids MI, Milwaukee WI, Chicago IL, Detroit MI,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06526195
Recruiting
Active & Responsive
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
for
Mesial Temporal Lobe Epilepsy
Location: Grand Rapids MI, Milwaukee WI, Cleveland OH,
Sponsor: UniQure Biopharma B.V.
Sex: All
Age: 18 - 70+
Code: NCT06063850
Phase 1, Phase 2, Recruiting
Active & Responsive
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
for
Stone, Kidney, Stone Ureter
Location: Grand Rapids MI, Lansing MI, Midland MI, Cadillac MI,
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05866081
Recruiting
Active & Responsive
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: Grand Rapids MI, Wyoming MI, Kalamazoo MI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase 3, Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Grand Rapids MI, Madison WI, Indianapolis IN,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase 2, Recruiting
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies